A comparative clinical study to test the effect of Patoladi Kwatha and Patoladi Ghana Vati in the management of Vatarakta w.s.r. to Gouty Arthritis

An open randomized comparative clinical study to evaluate the effect of Patoladi Kwatha and Patoladi Ghana Vati in the management of Vatarakta w.s.r.to Gouty Arthritis - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084338

Enrollment

Registered

2025-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E729- Disorder of amino-acid metabolism,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having serum uric acid level more than 7mg/dl(male)and 6mg/dl(female). Patients willing to participate for the entire duration pf 1 month. Patients of either gender between age group between 20-70 years.

Exclusion criteria

Exclusion criteria: Patients not willing for trial. Patients suffering from chronic renal,respiratory,cardiac and hepatic disorders. Patients who has completed participation in any other clinical trial during the past 3 months. Any condition which the investigator thinks may compromise with the safety of the subject. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
To lower the serum uric acid levels and relief in symptoms of patients with Gouty Arthritis.Timepoint: 30 days	—

Secondary

Measure	Time frame
To assess the clinical safety of Patoladi Kwatha and Patoladi Ghana Vati.Timepoint: 30 days.	—

Countries

India

Contacts

Public ContactDr Shivali Thakur

drvijaychaudhary@gmail.com9418130228

Outcome results